Consistently, recent evidence demonstrates that electroconvulsive therapy (ECT) in major depression weakens symptomatology while reducing serotonin-1A receptor binding in the subgenual part of cingulate cortex [30] as well as decreasing left dorsolateral prefrontal connectivity [16]. This evidence concerns the gene HTR1A and major depressive disorder.